Infinity Pharmaceuticals reported $11.59M in Operating Expenses for its third fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Operating Expenses Change
Abbvie ABBV:US USD 10.21B 1.08B
Amgen AMGN:US USD 3.91B 504M
AstraZeneca AZN:LN USD 9.74B 495M
Bristol Myers Squibb BMY:US USD 8.75B 552M
Cytori Therapeutics CYTX:US USD 5.17M 47K
Eisai 4523:JP JPY 176.54B 283M
Eli Lilly And LLY:US USD 5.27B 12.8M
Genocea Biosciences GNCA:US USD 16.04M 2.63M
Gilead Sciences GILD:US USD 4.2B 26M
GlaxoSmithKline GSK:LN GBP 6.64B 790M
Infinity Pharmaceuticals INFI:US USD 11.59M 1.11M
Johnson & Johnson JNJ:US USD 17.97B 211M
Mirati Therapeutics MRTX:US USD 191.87M 9.31M
Novartis NOVN:VX USD 10.67B 183M
Pfizer PFE:US USD 13.23B 2.41B
Seattle Genetics SGEN:US USD 703.1M 72.49M
Tg Therapeutics TGTX:US USD 35.06M 4.48M
Vascular Biogenics VBLT:US USD 9.76M 78K
YTE INCY:US USD 684.93M 27.96M